Acyclovir: mechanism of antiviral action and potentiation by ribonucleotide reductase inhibitors.
Reardon
J E
JE
Division of Experimental Therapy, Wellcome Research Laboratories, Burroughs Wellcome Company, Research Triangle Park, North Carolina 27709.
Spector
T
T
D000212:Acyclovir / Q000378:metabolism / Q000494:pharmacology*; D001483:Base Sequence; D001711:Biotransformation; D004351:Drug Resistance; D004357:Drug Synergism; D008969:Molecular Sequence Data; D012264:Ribonucleotide Reductases / Q000037:antagonists & inhibitors*; D014779:Virus Replication / Q000187:drug effects
D012264:Ribonucleotide Reductases; D000212:Acyclovir